Is transperitoneal laparoscopic adrenalectomy for pheochromocytoma really more challenging? A propensity score-matched analysis
- PMID: 36705839
- PMCID: PMC10348962
- DOI: 10.1007/s40618-023-02013-7
Is transperitoneal laparoscopic adrenalectomy for pheochromocytoma really more challenging? A propensity score-matched analysis
Abstract
Purpose: Minimally invasive surgery is the gold standard treatment for adrenal masses, but it may be a challenging procedure in the case of pheochromocytoma (PHEO). The aim of the present study is to report the results of transperitoneal laparoscopic adrenalectomy (TLA) in cases of PHEO in comparison to other types of adrenal lesions.
Methods: From 1994 to 2021, 629 patients underwent adrenalectomy. Twenty-two and thirty-five patients, respectively, were excluded because they underwent bilateral and open adrenalectomy, leaving 572 patients for inclusion. Of these, 114 patients had PHEO (Group A), and 458 had other types of lesions (Group B). To adjust for potential baseline confounders, a propensity score matching (PSM) analysis was conducted.
Results: After PSM, 114 matched pairs of patients were identified from each group. Statistically significant differences were not observed when comparing the median operative time (85 and 90 min in Groups A and B, respectively, p = 0.627), conversion rate [6 (5.3%) in each group, p = 1.000], transfusion rate [4 (3.5%) and 3 (2.6%) in Groups A and B, respectively, p = 1.000], complication rate [7 (6.1%) and 9 (7.9%) in Groups A and B, respectively, p = 0.796), median postoperative hospital stay (3.9 and 3.6 days in Groups A and B, respectively, p = 0.110), and mortality rate [1 (0.9%) in each group, p = 1.000].
Conclusions: Based on this analysis, the results of TLA for PHEO are equivalent to those of TLA for other types of adrenal lesions, but the fundamental requirements are multidisciplinary patient management and adequate surgeon experience. Further prospective studies are required to draw definitive conclusions.
Keywords: Adrenal lesions; Open adrenalectomy (OA); Pheochromocytoma (PHEO); Propensity score matching (PSM); Transperitoneal laparoscopic adrenalectomy (TLA).
© 2023. The Author(s).
Conflict of interest statement
Diletta Corallino, Andrea Balla, Livia Palmieri, Isabella Sperduti, Monica Ortenzi, Mario Guerrieri and Alessandro M. Paganini declare that they have no conflict of interest or financial ties to disclose.
Similar articles
-
Comparison of retroperitoneal laparoscopic versus open adrenalectomy for large pheochromocytoma: a single-center retrospective study.World J Surg Oncol. 2019 Jun 29;17(1):111. doi: 10.1186/s12957-019-1649-x. World J Surg Oncol. 2019. PMID: 31253139 Free PMC article.
-
Comparison of transperitoneal laparoscopic versus open adrenalectomy for large pheochromocytoma: A retrospective propensity score-matched cohort study.Int J Surg. 2019 Jan;61:26-32. doi: 10.1016/j.ijsu.2018.11.018. Epub 2018 Nov 29. Int J Surg. 2019. PMID: 30503601
-
Comparison of synchronous bilateral transperitoneal and posterior retroperitoneal laparoscopic adrenalectomy: results of a multicenter study.Surg Endosc. 2021 Mar;35(3):1101-1107. doi: 10.1007/s00464-020-07474-y. Epub 2020 Mar 9. Surg Endosc. 2021. PMID: 32152673
-
Laparoscopic adrenalectomy (LA) vs open adrenalectomy (OA) for pheochromocytoma (PHEO): A systematic review and meta-analysis.Eur J Surg Oncol. 2020 Jun;46(6):991-998. doi: 10.1016/j.ejso.2020.02.009. Epub 2020 Feb 17. Eur J Surg Oncol. 2020. PMID: 32102743
-
Laparoscopic adrenalectomy for pheochromocytoma. A comparison to aldosteronoma and incidentaloma.Surg Endosc. 2004 Apr;18(4):621-5. doi: 10.1007/s00464-003-8827-0. Epub 2004 Mar 19. Surg Endosc. 2004. PMID: 15026894 Review.
Cited by
-
Current state-of-the-art of adrenal surgery in Italy: the cancer risk in surgical adrenal lesions (CRISAL) survey.Updates Surg. 2025 Sep;77(5):1551-1561. doi: 10.1007/s13304-025-02139-8. Epub 2025 Mar 17. Updates Surg. 2025. PMID: 40097867 Free PMC article.
-
Which surgical approach is more favorable for pheochromocytoma of different sizes (< 6 cm vs. ≥ 6 cm)? A single retrospective center experience.World J Surg Oncol. 2023 Sep 11;21(1):285. doi: 10.1186/s12957-023-03164-w. World J Surg Oncol. 2023. PMID: 37697366 Free PMC article.
References
-
- Fassnacht M, Assie G, Baudin E, Eisenhofer G, de la Fouchardiere C, Haak HR, de Krijger R, Porpiglia F, Terzolo M, Berruti A, ESMO Guidelines Committee Adrenocortical carcinomas and malignant phaeochromocytomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2020;31(11):1476–1490. doi: 10.1016/j.annonc.2020.08.2099. - DOI - PubMed
-
- Picchetto A, Paganini AM, Balla A, Quaresima S, Cantisani V, D'Ambrosio G, Lezoche E. Rare extra-adrenal paraganglioma mimicking a painful Schwannoma: case report. Ann Ital Chir. 2014;85(ePub):S2239253X14022907. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous